Bhupendra Shrestha
Research Subjects
Bhupendra Shrestha has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alindam Ghosh
Department of Pharmaceutical Science, DmbH Institute of Medical Science, Hooghly, West Bengal, India
1 shared publication - Avik Dutta
DmbH Institute of Medical Science, Dadpur, Puinan, Hooghly-712305, India
1 shared publication - Faruk Alam
Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, 781026, India
1 shared publication - Jithendar Reddy Mandhadi
Assam down town University Guwahati Assam India
1 shared publication - Mohidul Islam
Faculty of Pharmaceutical Science, Assam Down Town University, Sankar Madhab Path, Gandhi Nagar, Panikhaiti, Guwahati, Assam, India; 781026, India
1 shared publication - Moidul Islam Judder
Royal School of Pharmacy, The Assam Royal Global University, Guwahati, Assam, India
1 shared publication
Latest Publications
- 14 June 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (7) , e70524
Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation
Naringin, a citrus flavanone glycoside, inhibits CYP3A4 and P ‐glycoprotein, making it a clinically relevant modulator of drug bioavailability. Amlodipine, a widely prescribed calcium channel blocker, metabolised by CYP3A4, is susceptible to pharmacokinetic interactions with citrus‐derived flavonoids. A LC–MS bioanalytical method was developed and fully validated for simultaneous quantification of amlodipine and naringin in rat plasma per ICH M10(2022) guidelines. Separation was achieved on a Waters C18 column (250 * 4.6 mm, 3 μm) with gradient elution using 10 mM ammonium acetate (pH 3.0) and acetonitrile. Detection employed positive electrospray ionisation at m / z 409.02,579.2 and 271.1 for amlodipine, naringin and naringenin (internal standard), respectively. Protein precipitation by addition of acetonitrile was employed for sample preparation. Calibration curves were linear over 24.01–2020.6 ng/mL (amlodipine) and 94.01–2012 ng/mL (naringin). Precision (%CV ≤ 15%), accuracy (85%–115%), and stability under all tested conditions met acceptance criteria. The validated method was utilized to analyse the non‐compartmental pharmacokinetics study in Wistar albino rats after oral amlodipine (1 mg/kg), naringin (15 mg/kg), and their combination. Co‐administration led to increased amlodipine C max (~2.2‐fold; p < 0.01), AUC 0–∞ (~2.0‐fold; p < 0.01), and decreased oral clearance. This is the first simultaneous LC–MS approach in conformity with ICH M10 (202) that provides a reliable preclinical citrus flavonoid‐drug interaction tool.
- 14 June 2026
- Published by Wiley in Biomedical Chromatography
- Vol. 40 (7) , e70524
Simultaneous Determination of Amlodipine and Naringin in Rat Plasma by LC–MS: Method Development and Validation
Naringin, a citrus flavanone glycoside, inhibits CYP3A4 and P ‐glycoprotein, making it a clinically relevant modulator of drug bioavailability. Amlodipine, a widely prescribed calcium channel blocker, metabolised by CYP3A4, is susceptible to pharmacokinetic interactions with citrus‐derived flavonoids. A LC–MS bioanalytical method was developed and fully validated for simultaneous quantification of amlodipine and naringin in rat plasma per ICH M10(2022) guidelines. Separation was achieved on a Waters C18 column (250 * 4.6 mm, 3 μm) with gradient elution using 10 mM ammonium acetate (pH 3.0) and acetonitrile. Detection employed positive electrospray ionisation at m / z 409.02,579.2 and 271.1 for amlodipine, naringin and naringenin (internal standard), respectively. Protein precipitation by addition of acetonitrile was employed for sample preparation. Calibration curves were linear over 24.01–2020.6 ng/mL (amlodipine) and 94.01–2012 ng/mL (naringin). Precision (%CV ≤ 15%), accuracy (85%–115%), and stability under all tested conditions met acceptance criteria. The validated method was utilized to analyse the non‐compartmental pharmacokinetics study in Wistar albino rats after oral amlodipine (1 mg/kg), naringin (15 mg/kg), and their combination. Co‐administration led to increased amlodipine C max (~2.2‐fold; p < 0.01), AUC 0–∞ (~2.0‐fold; p < 0.01), and decreased oral clearance. This is the first simultaneous LC–MS approach in conformity with ICH M10 (202) that provides a reliable preclinical citrus flavonoid‐drug interaction tool.
- Open Access
- 27 October 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (11) , 2617-2630
Eco-Compatible Synthesis of Metal Nanoparticles: Influencing Parameters, Characterization, Advancement and Applications
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.
- 27 October 2025
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 37 (11) , 2617-2630
Open AccessEco-Compatible Synthesis of Metal Nanoparticles: Influencing Parameters, Characterization, Advancement and Applications
The field of nanotechnology continues to offer profound implications across biomedical, environmental and materials science domains with metallic nanoparticles (MNPs) at the forefront due to their size-dependent physical and chemical attributes. This review provides a critical evaluation of the biosynthesis of MNPs particularly gold (AuNPs) and silver nanoparticles (AgNPs) employing plant-derived phytochemicals and microbial metabolites as reducing and stabilizing agents. The biosynthetic route is compared against conventional top-down and bottom-up methods, with specific attention to the influence of synthesis parameters (e.g. pH, temperature, extract concentration) on nanoparticle morphology, yield and surface chemistry. The unique optical and surface plasmon resonance properties of noble metals are discussed in the context of their biomedical applications, notably in antimicrobial coatings, cancer therapeutics, drug delivery vectors and diagnostic platforms. Moreover, functional nanoparticles of other metals (Pd, Cu, Fe, Fe3O4, α-Fe2O4, and nZVI) are examined for their roles in catalysis, pollutant degradation and water treatment. The review also delineates analytical techniques employed in nanoparticle characterization, encompassing structural, compositional, and surface profiling. Finally, the clinical relevance and translational potential of green-synthesized MNPs are contextualized within the broader framework of sustainable nanomaterials development.